期刊文献+

微小核糖核酸-34a对大鼠肥厚心肌组织肌球蛋白重链α基因表达的调控 被引量:5

Regulation of MicroRNA-34a on Myosin Heavy Chain-α Expression in Rats With Left Ventricular Hypertrophic Tissue
下载PDF
导出
摘要 目的 :探讨微小核糖核酸-34a(miRNA-34a)对左心室肥厚大鼠心肌组织肌球蛋白重链α基因表达的调控及其意义。方法 :将40只雄性SD大鼠随机分为4组(n=10),分别为腹主动脉缩窄术后皮下注射miRNA-34a表达阻遏物组(ant-34a/AAC组),腹主动脉缩窄术后皮下注射miRNA-34a表达阻遏物阴性对照物组(con/AAC组),假手术后皮下注射miRNA-34a表达阻遏物组(ant-34a/SH组),假手术后皮下注射miRNA-34a表达阻遏物阴性对照物组(con/SH组)。模型建立第12周存活大鼠:ant-34a/AAC组6只,con/AAC组7只,ant-34a/SH组8只,con/SH组8只。测定各组大鼠左心室收缩压、左心室舒张末期压及压力最大变化速率,计算心肌肥厚指数,观察心肌组织病理学改变,应用荧光定量逆转录-聚合酶链反应(qRT-PCR)检测大鼠左心室心肌组织miRNA-34a、肌球蛋白重链α基因表达水平。结果:与con/AAC组相比,ant-34a/AAC组心肌肥厚指数、左心室收缩压、左心室舒张末期压以及miRNA-34a相对表达量降低,压力最大变化速率、肌球蛋白重链α基因相对表达量明显升高(P均<0.05)。与con/AAC组相比,con/SH组心肌肥厚指数、左心室收缩压、左心室舒张末期压以及miRNA-34a相对表达量明显降低,压力最大变化速率、肌球蛋白重链α基因相对表达量明显升高(P均<0.05)。与con/SH组相比,ant-34a/SH组miRNA-34a相对表达量明显降低,肌球蛋白重链α基因相对表达量明显升高(P均<0.05),心肌肥厚指数、左心室收缩压、左心室舒张末期压、压力最大变化速率差异无统计学意义(P>0.05)。结论:压力负荷性左心室肥厚大鼠心肌组织中miRNA-34a表达上调,肌球蛋白重链α基因表达减少,利用特异性阻遏物阻断miRNA-34a表达可使大鼠肥厚心肌组织肌球蛋白重链α基因表达水平增高,减轻或者延缓心肌肥厚、提高心肌顺应性、改善心功能。 Objective: To explore the regulation effect of microRNA-34a (miR-34a) on myosin heavy chain α (α-MHC) expression in rats of left ventricular hypertrophic tissue with overloaded pressure. Methods: The cardiac hypertrophy rats' model was established by abdominal aortic constriction (AAC), and 40 SD rats were randomly divided into 4 groups. ① AAC rats with LNA-anti-miR-34a (ant-34a/AAC) group, ② AAC rats with LNA-control-34a (con/AAC) group, and ③ sham operation rats with LNA-anti-miR-34a (ant-34a/SH) group, ④ con/ SH group, n=10 in each group. With 12 weeks treatment, the surviving conditions were as 6 in ant-34a/AAC group, 7 in con/AAC group, and 8 in ant-34a/SH group, 8 in con/SH group. The left ventricular systolic pressure (LVSP), left ventricular eud distolic pressure (LVEDP), the maximum changing rate of pressure (±LVdp/dt)max, heart weight index (HM/ BM) and cardiac index (LVM/BM) were calculated, the pathological changes of myocardial tissue was observed and the expressions of miR-34a and α-MHC in the left ventricular tissue were analyzed. Results: Compared with con/AAC group, the ant-34a/AAC group had decreased HM/BM, LVSP, LVEDP and miR-34a expression, increased (±LLVdp/dt)max and α-MHC expression, all P〈0.05. Compared with con/AAC group, the con/SH group showed decreased HM/BM, LVSP, LVEDP and rniR-34a expression, increased (±LVdp/dt)max and et-MHC expression, all P〈0.05. Compared with con/SH group, the ant-34a/SH group presented decreased miR-34a expression and increased a-MHC expression, both P〈0.05; the HM/BM, LVSP, LVEDP and (±LVdp/dt)max were similar, all P〉0.05. Conclusion: The rats of left ventricular hypertrophy with overloaded pressure had increased miR-34a and decreased α-MHC, LNA-anti-miR-34a could elevate α-MHC expression and therefore, reduce or delay the myocardial hypertrophy and improve the cardiac function.
出处 《中国循环杂志》 CSCD 北大核心 2014年第2期138-141,共4页 Chinese Circulation Journal
基金 河南省科技厅科研基金(72102310023)
关键词 心肌肥厚 微小核糖核酸-34a 肌球蛋白重链α Ventricular hypertrophic MicroRNA-34a Myosin heavy chain-α
  • 相关文献

参考文献20

二级参考文献166

  • 1Liu G, Zhang S, He J, et al. The influence of chain length and base sequence on the pharmacokinetic behavior of 99mTc-morphlinos in mice[J]. Q J Nucl Med, 2002, 46(3) :233 - 243.
  • 2Henry SP. Evaluation of the taxicity of ISIS 2302, a phospho rahioate oligonucleotide, in a four-week study in cynomolgus monkeys[J]. Toxicology, 1997, 120(2):145- 155.
  • 3White PJ, Gray AC, Fogarty RD, et al. C-5 propyne-modified oligonucleotides penetrate the epidermis in psoriatic and not normal human skin after topical application[J]. J Invest Dermatol, 2002, 118(6):1003- 1007.
  • 4Burkhart CA, Cheng AJ, Madafiglio J, et al. Effects of MYCN antisense oligonucleotide administration on tumorigenesis in a murine model of neurobbastoma[J]. J Natl Cancer Inst, 2003, 95(18):1394- 1403.
  • 5Stewart DJ, Donehower RC, Eisenhauer EA, et al. A phase Ⅰ pharmacokinetic and pharmacodynamic study of the DNA methyltranferase 1 inhibitor MG98 administered twice weekly[J]. Ann Oncol, 2003, 14(5) :766 - 774.
  • 6De Rosa G, Bochot A, Quaglia F, et al. A new delivery system for antisense therapy: PLGA microspheres encapsulating oligonucleotide/polyethyleneimine solid complexes[J]. Int J Pharm, 2003, 254(1):89-93.
  • 7Geary RS, Khatsenko O, Bunker K, et al. Absolute bioavailahility of 2'-O-(2-methoxyethyl)-modified antisense oligonucleotides following intraduodenal instillation in rats[J]. J Pharmacol Exp Ther, 2001, 296(3):898-904.
  • 8Yu RZ, Geary RS, Monteith DK. Tissue disposition of 2'-O-(2-methoxy) ethyl modified antisense oligonucleotides in monkeys[J]. J Pharm Sci, 2004, 93(1):48-59.
  • 9Maksymowych WP, Blackburn WD Jr, Tami JA, et al. A randomized, placebo controlled trial of an antisense oligodeoxynucleotide to intercellular adhesion molecule-1 in the treatment of severe rheumatoid arthritis[J]. J Rheumatol, 2002, 29(3) :447 - 453.
  • 10Geary RS, Yu RZ. Pharmacokinetics of a tumor necrosis factor-alpha phosphorothioate 2'-O-( 2-methoxyethyl)-modified antisense oligonucleotide: comparison across species[J]. Drug Metab Dispos, 2003, 31(11):1419-1428.

共引文献138

同被引文献65

  • 1王旭丹,杨惠玲,郭禹标,梁志慧,赵睿颖,夏云飞,苏勇,Mong-Hong Lee,王瑾,郑芹.不同辐射抗拒鼻咽癌细胞微小RNA差异表达的研究[J].中国病理生理杂志,2007,23(6):1045-1048. 被引量:25
  • 2高佳莉,罗玉萍,李思光.miR-34基因家族的分子进化[J].Zoological Research,2007,28(3):271-278. 被引量:13
  • 3ZHANG C. MicroRNAs: role in cardiovascular biolo- gy and disease [J]. Clin Sci, 2008, 114: 699-706.
  • 4LEE R C, FEINBAUM R L, AMBROS V. The C. elegants beterochronic gene lin-4 encoded small RNAs with antisense complementarity to lin-14 [J]. Cell, 1993, 75: 843-854.
  • 5CALLIS T E, PANDYA K, SEOK H Y. MicroR- NA-208a is a regulator of cardiac hypertrophy and conduction in mice [J]. J Clin Invest, 2009, 9: 2772-2786.
  • 6VINOGRADOV S V, BATRAKOVA E V, LI S, et al. Mixed polymer micelles of amphiphilic and cationic copolymers for delivery of antisense oligonucleotides [J]. J Drug Target, 2004, 12: 517-526.
  • 7ZHAO X, PAN F, ZHANG Z, et al. Nanostructure of polyplexes formed between cationic diblock copoly- mer and antisense oligodeoxynucleotide and its influ- ence on cell transfection efficiency [J]. Biomacromol- ecules, 2007: 3493-3502.
  • 8YOO H, JULIANO R L. Enhanced delivery of anti- sense oligonucleotides with fluorophore-conjugated PAMAM dendrimers [J]. Nucleic Acids Res, 2000, 28: 4225-4231.
  • 9VINOGRADOV S V, BATRAKOVA E V, LI S, et al. Mixed polymer micelles of amphiphilic and cationic copolymers for delivery of antisense oligonucleotides [J]. J. Drug Targeting , 2004, 12: 517-526.
  • 10BRAUNWALD E. The war against heart failure: theLancetlecture [J]. 2015, 385: 812-824.

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部